$CACI earnings report

Fiscal 2027 first-quarter revenues of $2.5 billion, up 8.2% YoY; adjusted diluted EPS of $7.66, up 11.8% YoY; fiscal year 2027 revenue and earnings guidance raised. AlphAI read Caci International's fiscal 2027 first quarter filing as strong. 2 quarters are on record below.

fiscal 2027 first quarter

AlphAI · Earnings readCACI · fiscal 2027 first quarter · ended September 30, 2026

Fiscal 2027 first-quarter revenues of $2.5 billion, up 8.2% YoY; adjusted diluted EPS of $7.66, up 11.8% YoY; fiscal year 2027 revenue and earnings guidance raised.

✓Strong quarter

Revenue, operating income, adjusted net income, adjusted diluted EPS, EBITDA, EBITDA margin, funded backlog, and technology revenue increased year over year, while the company raised fiscal year 2027 revenue, adjusted net income, and adjusted diluted EPS guidance.

Revenue
$2.47B
8.2% y/y
Department of War
$1.35B
14.8% y/y
EPS · non-GAAP
$7.66
11.8% y/y
Fiscal Year 2027 outlook
$10,700 - $10,900

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended 9/30/2026GAAP$2.47B–8.2%
Revenue organic growth, three months ended 9/30/2026other2.1%––
Direct costs, three months ended 9/30/2026GAAP$1.60B–3.3%
Indirect costs and selling expenses, three months ended 9/30/2026GAAP$550.1M–16.1%
Depreciation and amortization, three months ended 9/30/2026GAAP$79.27M–46.0%
Total costs of revenues, three months ended 9/30/2026GAAP$2.23B–7.3%
Income from operations, three months ended 9/30/2026GAAP$247.5M–16.6%
Interest expense and other, net, three months ended 9/30/2026GAAP$73.24M–58.6%
Income before income taxes, three months ended 9/30/2026GAAP$174.3M–4.9%
Income taxes, three months ended 9/30/2026GAAP$43.92M–6.4%
Net income, three months ended 9/30/2026GAAP$130.4M–4.5%
Basic earnings per share, three months ended 9/30/2026GAAP$5.90–4.1%
Diluted earnings per share, three months ended 9/30/2026GAAP$5.84–3.7%
Weighted-average basic shares outstanding, three months ended 9/30/2026GAAP22,100–0.5%
Weighted-average diluted shares outstanding, three months ended 9/30/2026GAAP22,316–0.7%
Adjusted net income, three months ended 9/30/2026non-GAAP$171.0M–12.7%
Adjusted diluted EPS, three months ended 9/30/2026non-GAAP$7.66–11.8%
EBITDA, three months ended 9/30/2026non-GAAP$328.8M–22.4%
EBITDA margin, three months ended 9/30/2026non-GAAP13.3%––
Net cash provided by operating activities, three months ended 9/30/2026GAAP$161.3M––
Net cash provided by operating activities excluding MARPA, three months ended 9/30/2026non-GAAP$144.8M–(9.5)%
Capital expenditures, three months ended 9/30/2026GAAP−$11.36M––
Free cash flow, three months ended 9/30/2026non-GAAP$133.5M–(6.6)%
Days sales outstanding, three months ended 9/30/2026other59––
Contract awards, three months ended 9/30/2026other$4.83B–(3.4)%
Book-to-bill, first quarter of fiscal year 2027other2.0x––
Total backlog as of September 30, 2026other$34B–0.3%
Funded backlog as of September 30, 2026other$6.2B–14.8%

Segments

SegmentRevenueq/qy/y
Department of War54.8% of revenues.$1.35B–14.8%
Intelligence Community24.7% of revenues.$612.0M–2.6%
Federal civilian agencies16.0% of revenues.$396.4M–(3.7)%
Commercial and other4.5% of revenues.$112.0M–12.1%
Cost-plus-fee52.8% of revenues by contract type.$1.31B–(5.5)%
Fixed-price33.2% of revenues by contract type.$821.8M–34.4%
Time-and-materials14.0% of revenues by contract type.$346.5M–18.0%
Prime Contractor89.3% of revenues by prime or subcontractor.$2.21B–6.4%
Subcontractor10.7% of revenues by prime or subcontractor.$265.4M–25.9%
Technology58.6% of revenues by technology or expertise.$1.45B–11.4%
Expertise41.4% of revenues by technology or expertise.$1.03B–3.9%

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Fiscal Year 2027 outlook

  • Revenue$10,700 - $10,900
  • NoteAdjusted net income, a non-GAAP measure: $740 - $760
  • NoteAdjusted diluted earnings per share, a non-GAAP measure: $33.18 - $34.08
  • NoteDiluted weighted average shares: 22.3
  • NoteFree cash flow, a non-GAAP measure: At least $900
  • NoteNet income: $579 --- $599
  • NoteDiluted EPS: $25.96 --- $26.86
  • NoteNet cash provided by operating activities: $1,015
  • NoteCash provided by MARPA: —
  • NoteNet cash provided by operating activities excluding MARPA: $1,015
  • NoteCapital expenditures: $(115)

Capital returns

  • Repurchases of common stock: $(4,406)
  • Proceeds from employee stock purchase plans: $4,031
  • Payment of taxes for equity transactions: $(71)

What drove it

  • Revenue increased 8.2% year-over-year, including 2.1% organic growth.
  • The increase in income from operations was driven by higher revenues and gross profit.
  • Growth in diluted earnings per share and adjusted diluted earnings per share was driven by higher income from operations, partially offset by higher interest expense and a higher tax provision.
  • Technology revenue increased 11.4%, while expertise revenue increased 3.9%.
  • Fixed-price revenue increased 34.4% and time-and-materials revenue increased 18.0%, while cost-plus-fee revenue decreased 5.5%.
  • Department of War revenue increased 14.8%; federal civilian agencies revenue decreased 3.7%.
  • Approximately 61% of $4.8 billion of contract awards was for new business to CACI.

Concerns

  • Interest expense and other, net increased 58.6% to $73,240.
  • Net cash provided by operating activities excluding MARPA decreased 9.5% to $144,848, driven primarily by higher working capital.
  • Free cash flow decreased 6.6% to $133,489.
  • Contract awards decreased 3.4% to $4,828,329.
  • Total backlog increased 0.3% to $34.0 billion.
  • Federal civilian agencies revenue decreased 3.7% and cost-plus-fee revenue decreased 5.5%.

What to watch

  • Execution against fiscal year 2027 revenue guidance of $10,700 - $10,900.
  • Execution against fiscal year 2027 adjusted net income guidance of $740 - $760 and adjusted diluted EPS guidance of $33.18 - $34.08.
  • Free cash flow delivery of at least $900, including net cash provided by operating activities excluding MARPA of $1,015 and capital expenditures of $(115).
  • Funded backlog growth following the reported $6.2 billion balance and 14.8% increase.
  • Cash conversion and working-capital trends after the decrease in net cash provided by operating activities excluding MARPA.

Balance sheet and cash flow

  • Cash and cash equivalents as of 9/30/2026: $279,389; as of 6/30/2026: $191,756
  • Accounts receivable, net as of 9/30/2026: $1,722,873; as of 6/30/2026: $1,705,087
  • Current portion of long-term debt as of 9/30/2026: $46,750; as of 6/30/2026: $46,750
  • Long-term debt, net of current portion as of 9/30/2026: $4,789,313; as of 6/30/2026: $4,854,759
  • Total assets as of 9/30/2026: $11,947,535; as of 6/30/2026: $11,819,644
  • Total liabilities as of 9/30/2026: $7,320,844; as of 6/30/2026: $7,356,947
  • Total shareholders’ equity as of 9/30/2026: $4,626,691; as of 6/30/2026: $4,462,697
  • Proceeds from borrowings: $1,211,500; prior year: $541,000
  • Principal payments on borrowings: $(1,278,188); prior year: $(682,688)
  • Net cash used in financing activities: $(67,134); prior year: $(142,238)
  • Net change in cash and cash equivalents: $87,633; prior year: $26,839

Analysis

CACI reported fiscal 2027 first-quarter revenue of $2,474,597, up 8.2%, including 2.1% organic growth. Income from operations increased 16.6% to $247,528, outpacing revenue growth. Net income increased 4.5% to $130,367, while adjusted net income increased 12.7% to $170,957 and adjusted diluted EPS increased 11.8% to $7.66. The release attributes EPS growth to higher income from operations, partly offset by higher interest expense and a higher tax provision.

Mix favored technology and fixed-price work. Technology revenue increased 11.4% to $1,449,336, compared with 3.9% growth in expertise revenue to $1,025,261. Fixed-price revenue rose 34.4% to $821,826 and time-and-materials revenue rose 18.0% to $346,464, while cost-plus-fee revenue declined 5.5% to $1,306,307. Department of War revenue increased 14.8% to $1,354,257, whereas federal civilian agencies revenue declined 3.7% to $396,398.

Profit conversion strengthened on the reported measures. EBITDA increased 22.4% to $328,828 and EBITDA margin rose to 13.3% from 11.7%. Depreciation and amortization increased 46.0% to $79,267, while interest expense and other, net increased 58.6% to $73,240. Cash conversion was softer: net cash provided by operating activities excluding MARPA declined 9.5% to $144,848 and free cash flow declined 6.6% to $133,489, with the release citing higher working capital.

Demand indicators were constructive despite a year-over-year decline in awards. Contract awards were $4,828,329, down 3.4%, but book-to-bill was 2.0x and approximately 61% of awards were for new business to CACI. Total backlog was $34.0 billion, up 0.3%, while funded backlog increased 14.8% to $6.2 billion. Management raised fiscal year 2027 guidance for revenue to $10,700 - $10,900, adjusted net income to $740 - $760, and adjusted diluted EPS to $33.18 - $34.08, while maintaining free cash flow guidance at at least $900.

The balance sheet showed cash and cash equivalents of $279,389 as of 9/30/2026 and long-term debt, net of current portion, of $4,789,313. During the quarter, the company reported $1,211,500 of proceeds from borrowings and $(1,278,188) of principal payments on borrowings. Repurchases of common stock were $(4,406). The central figures to monitor are delivery against the increased revenue and earnings outlook, free-cash-flow execution, funded backlog growth, and the effect of higher interest expense and working capital on earnings and cash generation.

Management, verbatim

Our first quarter results represent a strong start to fiscal year 2027, highlighted by revenue and EBITDA growth, strong EBITDA margin, and healthy free cash flow. We also delivered a 2.0x book-to-bill and another quarter of double-digit funded backlog growth. Our mission proximity, software-defined approach, ability to invest ahead of customer need, and superior execution continue to differentiate CACI and drive our performance.

John Mengucci, CACI President and Chief Executive Officer

Based on our results, large and growing backlog, and healthy pipeline, we are raising our fiscal year 2027 revenue and earnings profit outlook while reaffirming guidance for other financial metrics. We remain confident in our ability to drive long-term growth in free cash flow per share and deliver exceptional value for our customers and shareholders.

John Mengucci, CACI President and Chief Executive Officer

Not in the filing

stated, not guessed
  • GAAP gross margin was not reported.
  • Non-GAAP gross margin was not reported.
  • Operating expense guidance was not reported.
  • Tax rate guidance was not reported.
  • Prior-quarter comparisons for reported first-quarter metrics were not reported.
  • A previous earnings release outlook was not provided for comparison with actual results.

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Fiscal 2026 fourth quarter and full year

AlphAI · Earnings readCACI · Fiscal 2026 fourth quarter and full year · ended June 30, 2026

Annual revenues of $9.6 billion, up 10.9% YoY; annual net income of $535.8 million; diluted EPS of $24.16, up 8.2% YoY; annual adjusted diluted EPS of $29.83, up 12.7% YoY; annual EBITDA of $1,173.9 million and EBITDA margin of 12.3%.

✓Strong quarter

Fiscal 2026 revenue, operating income, adjusted diluted EPS, EBITDA, operating cash flow excluding MARPA, and free cash flow all increased year-over-year, while fourth-quarter revenue growth accelerated and funded backlog increased 28.6%.

Revenue
$ 2,709.1
17.6% y/y · 15.2% q/q
EPS · non-GAAP
$ 8.91
6.1% y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Fourth-quarter revenuesGAAP$ 2,709.115.2%17.6%
Fourth-quarter income from operationsGAAP$ 272.2–31.7%
Fourth-quarter net incomeGAAP$ 156.8–(0.7)%
Fourth-quarter adjusted net incomenon-GAAP$ 198.1–6.6%
Fourth-quarter diluted earnings per shareGAAP$ 7.05–(1.3)%
Fourth-quarter adjusted diluted earnings per sharenon-GAAP$ 8.91–6.1%
Fourth-quarter EBITDAnon-GAAP$ 353.1–33.5%
Fourth-quarter net cash provided by operating activities excluding MARPAnon-GAAP$ 279.7–67.4%
Fourth-quarter free cash flownon-GAAP$ 232.9–67.4%
Fourth-quarter days sales outstanding (DSO)other55––
Fiscal year revenuesGAAP$ 9,567.8–10.9%
Fiscal year income from operationsGAAP$ 919.8–20.4%
Fiscal year net incomeGAAP$535.8M–7.2%
Fiscal year adjusted net incomenon-GAAP$661.6M–11.6%
Fiscal year diluted earnings per shareGAAP$ 24.16–8.2%
Fiscal year adjusted diluted earnings per sharenon-GAAP$ 29.83–12.7%
Fiscal year EBITDAnon-GAAP$1.17B–21.4%
Fiscal year EBITDA marginnon-GAAP12.3%––
Fiscal year net cash provided by operating activities excluding MARPAnon-GAAP$ 842.1–65.7%
Fiscal year free cash flownon-GAAP$ 735.4–66.2%
Fourth-quarter contract awardsother$1.6B––
Fiscal year contract awardsother$10.2B––
Fiscal year book-to-billother1.1x––
Total backlog as of June 30, 2026other$32B–1.9%
Funded backlog as of June 30, 2026other$5.4B–28.6%

What drove it

  • Fourth-quarter revenue increased 17.6% year-over-year, driven by 11.6% organic growth.
  • Fourth-quarter revenue grew 15.2% sequentially.
  • The increase in fourth-quarter income from operations was driven by higher revenues and gross profit.
  • The increase in cash from operations, excluding MARPA, was driven primarily by strong working capital management.
  • Approximately 40% of fourth-quarter contract awards were for new business to CACI.

Concerns

  • Fourth-quarter net income declined (0.7)% year-over-year to $ 156.8.
  • Fourth-quarter diluted earnings per share declined (1.3)% year-over-year to $ 7.05.
  • CACI stated that the slight decrease in diluted earnings per share was driven by increased interest expense as a result of the ARKA acquisition and a higher tax provision.
  • Total backlog increased 1.9% year-over-year, below the 28.6% increase in funded backlog.

What to watch

  • Fiscal year 2027 guidance figures were not included in the supplied filing text.
  • Conversion of $32.0 billion of total backlog and $5.4 billion of funded backlog into revenue.
  • Cash flow performance and working capital management following fiscal year free cash flow of $ 735.4.
  • Interest expense associated with the ARKA acquisition and the tax provision, which affected fourth-quarter diluted earnings per share.

Balance sheet and cash flow

  • Fourth-quarter net cash provided by operating activities excluding MARPA, a non-GAAP measure: $ 279.7, compared with $ 167.1; 67.4%.
  • Fourth-quarter free cash flow, a non-GAAP measure: $ 232.9, compared with $ 139.1; 67.4%.
  • Fiscal year net cash provided by operating activities excluding MARPA, a non-GAAP measure: $ 842.1, compared with $ 508.1; 65.7%.
  • Fiscal year free cash flow, a non-GAAP measure: $ 735.4, compared with $ 442.5; 66.2%.
  • The DSO calculations for three months ended June 30, 2026 and 2025, exclude the impact of the Company’s Master Accounts Receivable Purchase Agreement (MARPA), which was 7 days and 8 days, respectively.

Analysis

CACI closed fiscal 2026 with fourth-quarter revenue of $ 2,709.1, up 17.6% year-over-year and 15.2% sequentially. The company attributed the year-over-year increase to 11.6% organic growth. Fourth-quarter income from operations rose 31.7% to $ 272.2, which CACI attributed to higher revenues and gross profit. Fourth-quarter EBITDA increased 33.5% to $ 353.1.

Full-year revenue increased 10.9% to $ 9,567.8, while income from operations increased 20.4% to $ 919.8. Fiscal-year EBITDA increased 21.4% to $ 1,173.9, and the company reported an EBITDA margin of 12.3%. GAAP net income increased 7.2% to $ 535.8 and diluted EPS increased 8.2% to $ 24.16. Adjusted net income rose 11.6% to $ 661.6, and adjusted diluted EPS rose 12.7% to $ 29.83.

Cash generation strengthened materially. Fourth-quarter net cash provided by operating activities excluding MARPA increased 67.4% to $ 279.7, and fourth-quarter free cash flow increased 67.4% to $ 232.9. For the full year, net cash provided by operating activities excluding MARPA rose 65.7% to $ 842.1 and free cash flow rose 66.2% to $ 735.4. CACI attributed the quarterly operating-cash-flow increase primarily to strong working capital management.

The award and backlog data point to continued demand. Fiscal-year contract awards were $10.2 billion and book-to-bill was 1.1x. Fourth-quarter awards totaled $1.6 billion, with approximately 40% for new business to CACI. Total backlog was $32.0 billion, up 1.9%, while funded backlog was $5.4 billion, up 28.6%. The supplied text says CACI issued fiscal year 2027 guidance and expects strong cash flow, driven by strong revenue growth, margin expansion, and efficient working capital management, but it does not include the underlying guidance ranges or targets.

The key near-term earnings pressure was in GAAP fourth-quarter earnings per share. Net income declined (0.7)% to $ 156.8 and diluted EPS declined (1.3)% to $ 7.05, despite higher operating income. CACI cited increased interest expense resulting from the ARKA acquisition and a higher tax provision. Adjusted diluted EPS nevertheless grew 6.1% to $ 8.91.

Management, verbatim

CACI’s outstanding fiscal year 2026 performance demonstrates the power of our differentiated strategy, our relentless focus on execution, and underscores the technology-first national security company we have become. In a challenging environment, we grew free cash flow by 66%, delivered high-single digit organic revenue growth, expanded EBITDA margin to 12.3%, won $10 billion in contract awards, and grew both funded and total backlog.

John Mengucci, CACI President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Fiscal year 2027 numerical revenue guidance
  • Fiscal year 2027 gross-margin guidance
  • Fiscal year 2027 operating-expense guidance
  • Fiscal year 2027 tax-rate guidance
  • Fiscal year 2027 EPS, EBITDA, cash flow, free cash flow, contract-award, or backlog guidance figures
  • Prior fiscal year guidance for comparison
  • Segment revenue and segment profitability
  • Gross profit and gross margin
  • Operating expenses
  • Cash balance
  • Debt balance
  • GAAP cash provided by operating activities
  • Capital expenditures
  • Share repurchases
  • Dividends
  • Fiscal-year DSO
  • Detailed fiscal-year 2026 narrative following the truncated filing text

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about CACI earnings dates

When is Caci International's next earnings date?
AlphAI has no confirmed date for CACI yet. We publish an earnings date only once the company has set it, so this page shows one the day that happens.
Where does the date come from, and why is there no estimate?
A confirmed date comes from the company's own announcement. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so AlphAI shows nothing until the company confirms. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.